PF-Atlas › Clinical Trials › NCT04411901
The Role of Vitamin D3 in Pediatric Bronchiectasis Severity
Cholecalciferol · Phase 2
Registry ID
NCT04411901
Phase
Phase 2
Status
Completed
Drug / intervention
Cholecalciferol (vitaminD3)
Sponsor
Heba Omara
Start
2018-03-01
Enrollment
40
Locations
1
About this trial
Vitamin D3 therapy was effective in decreasing the frequency of pulmonary exacerbations and preserving lung functions , thereby improving the disease severity even more in non CF than CF bronchiectasis patients
Explore related
Related trials
Medical disclaimer. This page summarizes public trial data for NCT04411901 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.